# Carl Zeiss Meditec AG clinical trials: 37 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 37 trials with Carl Zeiss Meditec AG as lead sponsor, 3 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Carl Zeiss Meditec AG: 37 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/carl-zeiss-meditec-ag

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 37
- Recruiting or not yet: 3
- Read on: November 19, 2026

## Trials

The 25 newest of 37, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 13, 2026 | NCT07471295 | Toric Performance And Constant Evaluation | Carl Zeiss Meditec AG | Phase 4 | Recruiting | Cataract | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07471295) |
| December 22, 2025 | NCT07297719 | Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation | Carl Zeiss Meditec AG | Observational | Completed | Cataract Senile | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297719) |
| July 29, 2025 | NCT07092020 | Extended Depth of Focus (EDF) Intraocular Lens (IOL) Versus Monofocal Intracoular Lens (IOL) | Carl Zeiss Meditec AG | Not applicable | Completed | Cataract Senile | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07092020) |
| July 24, 2025 | NCT07084545 | Evaluation of Cataract Surgery Outcomes in Patients With Prior Laser Vision Correction Implanted With the CT LUCIA Lens | Carl Zeiss Meditec AG | Observational | Recruiting | Postoperative Visual Outcomes Following Cataract Surgery in Patients With Prior Myopic Corneal Laser Vision Correction | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07084545) |
| May 7, 2025 | NCT06960785 | Evaluation of Refractive Outcomes in Patients Undergoing PRESBYOND Using the MEL90 Excimer Laser | Carl Zeiss Meditec AG | Observational | Not yet recruiting | Presbyopia | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06960785) |
| May 24, 2024 | NCT06428955 | Evaluation of a Monofocal Intraocular Lens | Carl Zeiss Meditec AG | Phase 4 | Completed | Cataract | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06428955) |
| February 8, 2024 | NCT06247683 | Study to Confirm Safety and Performance of a New Multifocal IOL | Carl Zeiss Meditec AG | Not applicable | Completed | Cataract Senile | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06247683) |
| January 5, 2024 | NCT06192901 | Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery | Carl Zeiss Meditec AG | Observational | Completed | Senile Cataract | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06192901) |
| November 1, 2023 | NCT06111222 | Visual Performance of Patients Implanted With a Multifocal IOL | Carl Zeiss Meditec AG | Not applicable | Completed | Cataract, Refractive Lens Exchange | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06111222) |
| December 12, 2022 | NCT05646004 | 621 Real World Study | Carl Zeiss Meditec AG | Not applicable | Completed | Senile Cataract | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05646004) |
| July 18, 2022 | NCT05462067 | Combined EDOF / Trifocal | Carl Zeiss Meditec AG | Not applicable | Completed | Cataract | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05462067) |
| July 14, 2022 | NCT05458661 | Feasibility Investigation of Biometry and Tomography Measurements in a Heterogeneous Patient Cohort | Carl Zeiss Meditec AG | Not applicable | Unknown | Cataract, Lens Opacities, Artificial Lens Implant, Corneal Astigmatism, Corneal Defect, Corneal Deformity | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05458661) |
| January 21, 2022 | NCT05201027 | Study to Optimize the IOL Constant of a New Multifocal Intraocular Lens | Carl Zeiss Meditec AG | Not applicable | Terminated | Cataract Senile | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05201027) |
| August 10, 2021 | NCT04998409 | Evaluation of a Spherical Hydrophilic Acrylic Intraocular Lens | Carl Zeiss Meditec AG | Observational | Completed | Cataract Senile | 242 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04998409) |
| July 19, 2021 | NCT04967612 | Visual Perception After Virtual Implantation | Carl Zeiss Meditec AG | Not applicable | Completed | Healthy | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04967612) |
| May 28, 2021 | NCT04907500 | Prospective Evaluation of an Hydrophilic Acrylic Intraocular Lens | Carl Zeiss Meditec AG | Not applicable | Completed | Cataract Senile | 387 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04907500) |
| May 13, 2021 | NCT04884672 | PMCF Study on SMILE Treatment of Myopia With and Without Astigmatism | Carl Zeiss Meditec AG | Observational | Completed | Myopia, Astigmatism | 237 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04884672) |
| March 11, 2021 | NCT04793789 | Evaluation of an Hydrophilic Acrylic Intraocular Lens | Carl Zeiss Meditec AG | Observational | Completed | Cataract Senile | 249 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04793789) |
| March 9, 2021 | NCT04789538 | Safety and Effectiveness of an Hydrophilic Acrylic Intraocular Lens | Carl Zeiss Meditec AG | Observational | Completed | Cataract Senile | 328 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04789538) |
| February 5, 2021 | NCT04740788 | Study on Visual Performance of a Monofocal Intraocular Lens | Carl Zeiss Meditec AG | Observational | Completed | Cataract Senile | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04740788) |
| September 11, 2020 | NCT04545671 | Evaluation of a Trifocal Lens | Carl Zeiss Meditec AG | Observational | Completed | Cataract Senile | 389 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04545671) |
| August 20, 2020 | NCT04519814 | Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT) | Carl Zeiss Meditec AG | Not applicable | Completed | Primary Open-angle Glaucoma | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04519814) |
| February 5, 2020 | NCT04252716 | VISPER: Randomised Comparison of Two OVDs in Cataract Surgery | Carl Zeiss Meditec AG | Observational | Completed | Cataract Senile | 273 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04252716) |
| July 30, 2019 | NCT04037631 | Compare Visual Outcomes Using a New Diagnostic Device | Carl Zeiss Meditec AG | Observational | Terminated | Presbyopia | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04037631) |
| July 29, 2019 | NCT04036149 | To Compare Postoperative Horizontal Position Stability of the CT LUCIA 611P and the CT ASPHINA 409MP | Carl Zeiss Meditec AG | Not applicable | Completed | Cataract Senile | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04036149) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 4 | 4 |
| Not applicable | 21 |
| Observational | 12 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 28 |
| Terminated | 3 |
| Unknown | 2 |
| Recruiting | 2 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Cataract | 14 |
| Presbyopia | 3 |
| Astigmatism | 2 |
| Glaucoma, Open-Angle | 1 |
| Myopia | 1 |
| Hyperopia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Taiwanese restaurants in the United States](https://specstream.ai/data/businesses/taiwanese-restaurants/united-states)
- [Drive thru bars in the United States](https://specstream.ai/data/businesses/drive-thru-bars/united-states)
- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Basque restaurants in the United States](https://specstream.ai/data/businesses/basque-restaurants/united-states)
- [Janitorial companies in the United States](https://specstream.ai/data/businesses/janitorial-companies/united-states)
- [Vascular medicine practices in the United States](https://specstream.ai/data/businesses/vascular-medicine-practices/united-states)
